Tuberculosis in lung transplant recipients

Transplantation

Volumn 79, Issue 1, 2005, Pages 59-64

  Bravo, Carlos ^a   Roldán, Juan ^a   Roman, Antonio ^a   DeGrada, Javier ^a   Majo, Joaquim ^a   Guerra, Javier ^a   Monforte, Víctor ^a   Vidal, Rafael ^a   Morell, Ferran ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Isoniazid; Lung transplantation; Tuberculosis

Indexed keywords

AMPHOTERICIN B; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; ETHAMBUTOL; GANCICLOVIR; ISONIAZID; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PYRAZINAMIDE; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CHILD; CLINICAL ARTICLE; DYSPNEA; FEMALE; FEVER; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUBERCULOSIS, PULMONARY;

EID: 12344276472     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000147784.53188.DC     Document Type: Article

References (31)

1. Unilateral lung transplantation for pulmonary fibrosis: Toronto Lung Transplant Group. N Engl J Med 1986; 314: 1140-1145.
2. Dummer JS, Montero CG, Griffith BP, et al. Infections in heart-lung transplant recipients. Transplantation 1986; 41: 725-729.
3. Brooks RG, Hofflin JM, Jamieson SW, et al. Infectious complications in heart-lung transplant recipients. Am J Med 1985; 79: 412-422.
4. Griffith BP, Hardesty RL, Trento A, et al. Heart-lung transplantation: Lessons learned and future hopes. Ann Thorac Surg 1987; 43: 6-16.
5. Dromer C, Nashef SA, Velly JF, et al. Tuberculosis in transplanted lungs. J Heart Lung Transplant 1993; 12: 924-927.
6. Chaparro C, Kesten S. Infections in lung transplant recipients. Clin Chest Med 1997; 18: 339-351.
7. Veale D, Glasper PN, Gascoigne A, et al. Ciliary beat frequency in transplanted lungs. Thorax 1993; 48: 629-631.
8. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implications for management. Clin Infect Dis 1998; 27: 1266-1277.
9. Sakhuja V, Jha V, Varma PP, et al. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61: 211-215.
10. Malouf MA, Glanville AR. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med 1999; 160: 1611-1616.
11. Surveillance, planning, financing: WHO report 2003. Global tuberculosis control. Geneva, World Health Organization 2003, pp 1-215. WHO/ CDS/TB/2003.316.
12. Maurer JR, Frost AE, Estenne M, et al. International guidelines for the selection of lung transplant candidates: The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. Transplantation 1998; 66: 951-956.
13. Orriols R, Morell F, Curull V, et al. Impaired non-specific delayed cutaneous hypersensitivity in bird fancier's lung. Thorax 1989; 44: 132-135.
14. Roman A, Bravo C, Levy G, et al. Isoniazid prophylaxis in lung transplantation. J Heart Lung Transplant. 2000; 19: 903-906.
15. Roberts G, Koneman E, Yoo KM. Manual of clinical microbiology, Mycobacterium. American Society of Microbiology, Washington, DC, 1991.
16. Vestal AL. Procedures for the insolation and identification of mycobacteria. Atlanta, GA, Centers for Disease Control, U.S. Department of Health, Education and Welfare 1975.
17. Modry DL, Stinson EB, Oyer PE, et al. Acute rejection and massive cyclosporine requirements in heart transplant recipients treated with rifampin. Transplantation 1985; 39: 313-314.
18. Reference deleted.
19. Offermann G, Keller F, Molzahn M. Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampicin treatment. Am J Nephrol 1985; 5: 385-387.
20. Chemotherapy and management of tuberculosis in the United Kingdom: Recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society. Thorax 1998; 53: 536-548.
21. Aguado JM, Herrero JA, Gavalda J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain: Spanish Transplantation Infection Study Group, GESITRA. Transplantation 1997; 63: 1278-1286.
22. Sinnott JT, Emmanuel PJ. Mycobacterial infections in the transplant patient. Semin Respir Infect 1990; 5: 65-73.
23. Kesten S, Chaparro C. Mycobacterial infections in lung transplant recipients. Chest 1999; 115: 741-745.
24. Queipo JA, Broseta E, Santos M, et al. Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect 2003; 9: 518-525.
25. John GT, Shankar V. Mycobacterial infections in organ transplant recipients. Semin Respir Infect 2002; 17: 274-283.
26. Jonas V, Longiaru M. Detection of Mycobacterium tuberculosis by molecular methods. Clin Lab Med 1997; 17: 119-128.
27. Lee J, Yew WW, Wong CF, et al. Multidrug-resistant tuberculosis in a lung transplant recipient. J Heart Lung Transplant 2003; 22: 1168-1173.
28. Carlsen SE, Bergin CJ. Reactivation of tuberculosis in a donor lung after transplantation. AJR 1990; 154: 95-97.
29. Miller RA, Lanza LA, Kline JN, et al. Mycobacterium tuberculosis in lung transplant recipients. Am J Respir Crit Care Med 1995; 152: 374-376.
30. Al Majed SA. Study of paradoxical response to chemotherapy in tuberculous pleural effusion. Respir Med 1996; 90: 211-214.
31. De Gracia J, Curull V, Vidal R, et al. Diagnostic value of bronchoalveolar lavage in suspected pulmonary tuberculosis. Chest 1988; 93: 329-332.